In the external validation set, the expression of core genes was similar to that in the screening set, which were upregulated in DCM tissues with strong diagnostic performance (EXT1, AUC = 0.842; FRZB, AUC = 0.954) (Fig. 5C, D). This evidence concerns the gene FRZB and familial dilated cardiomyopathy.